Want to join the conversation?
$AMGN and Brussels-based biopharma company UCB announced the submission of a Biologics License Application (BLA) to the US FDA for romosozumab, an investigational antibody for treating osteoporosis in postmenopausal women at increased risk of fracture. The BLA is based on data from Phase 3 placebo-controlled FRAME study in about 7,200 patients.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?